Who Supplies Topotecan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Topotecan exports, with 45+ registered manufacturers shipping to buyers across 51+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 30.8% (export value: $1.2M). Close behind, VENUS REMEDIES LIMITED (3.3%, $122.5K). SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.0%, $111.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Topotecan? Top Manufacturers & Their Buyers
Flow of Topotecan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Topotecan Supplier Network — Key Market Intelligence
The Topotecan export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 30.8% share, shipping $1.2M worth of product across 414 shipments. The second-largest exporter, VENUS REMEDIES LIMITED, contributes $122.5K (3.3%) to the overall market. Combined, the top two suppliers alone account for 34.0% of all Topotecan exports, indicating a relatively concentrated supply base.
Across all 45 tracked manufacturers, the total Topotecan export value stands at $3.8M from 558 shipments. The market average shipment value is $6.7K. The single largest buyer relationship in terms of trade value is ACCORD HEALTHCARE POLSKA SP Z O O, receiving $257.0K worth of product.
The combined buyer network spans 14 named purchasing companies, including ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD FARMACUTICA LTDA., ALLOGA FRANCE, E P H K, VENUS PHARMA GMBH and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Topotecan exporter from India, with a market share of 30.8% and a total export value of $1.2M across 414 shipments. Their average shipment value of $2.8K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD HEALTHCARE POLSKA SP Z O O — $257.0K across 92 shipments (22.2% of this supplier's total exports)
• ACCORD FARMACUTICA LTDA. — $257.0K across 92 shipments (22.2% of this supplier's total exports)
• TO THE ORDER — $254.6K across 91 shipments (22.0% of this supplier's total exports)
• ACCORD HEALTHCARE POLSKA SP Z O O — $238.4K across 85 shipments (20.6% of this supplier's total exports)
• ALLOGA FRANCE — $148.6K across 53 shipments (12.9% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (414 shipments) at a per-shipment value of $2.8K, indicating a broad distribution network with many smaller, regular orders.
2VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the second-largest Topotecan exporter from India, with a market share of 3.3% and a total export value of $122.5K across 30 shipments. Their average shipment value of $4.1K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E P H K — $59.2K across 15 shipments (48.3% of this supplier's total exports)
• VENUS PHARMA GMBH — $23.3K across 6 shipments (19.1% of this supplier's total exports)
• L.B.S.A — $16.5K across 4 shipments (13.5% of this supplier's total exports)
• LABORATORIO BIOSANO — $12.7K across 3 shipments (10.4% of this supplier's total exports)
• H H B S — $10.7K across 3 shipments (8.7% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $4.1K, indicating a broad distribution network with many smaller, regular orders.
3SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Topotecan exporter from India, with a market share of 3.0% and a total export value of $111.1K across 4 shipments. Their average shipment value of $27.8K is above the market average of $6.7K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. M/S. SUN PHARMACEUTICALS MOROCCO LL is the dominant customer, accounting for 56.2% of this supplier's tracked business. Top customers include:
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $62.4K across 2 shipments (56.2% of this supplier's total exports)
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $37.4K across 1 shipments (33.7% of this supplier's total exports)
• M/S.SUN PHARMACEUTIC — $11.2K across 0 shipments (10.1% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $27.8K is 313% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.
4R.S. SURGIPHARM PRIVATE LIMITED
R.S. SURGIPHARM PRIVATE LIMITED is the fourth-largest Topotecan exporter from India, with a market share of 0.4% and a total export value of $13.7K across 7 shipments. Their average shipment value of $2.0K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
R.S. SURGIPHARM PRIVATE LIMITED serves 1 named buyer in our database. CENTRAL HOSPITAL82 A is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• CENTRAL HOSPITAL82 A — $13.7K across 7 shipments (100.0% of this supplier's total exports)
Key Insight: R.S. SURGIPHARM PRIVATE LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.
5UNITED BIOTECH PRIVATE LIMITED
UNITED BIOTECH PRIVATE LIMITED is the fifth-largest Topotecan exporter from India, with a market share of 0.3% and a total export value of $10.0K across 23 shipments. Their average shipment value of $436 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
UNITED BIOTECH PRIVATE LIMITED serves 5 named buyers in our database. M/S. NIKHIL PHARMA P is the dominant customer, accounting for 66.0% of this supplier's tracked business. Top customers include:
• M/S. NIKHIL PHARMA P — $6.6K across 15 shipments (66.0% of this supplier's total exports)
• MSNIKHIL PHARMA PRIV — $1.1K across 2 shipments (10.8% of this supplier's total exports)
• M/S. NIKHIL PHARMA P — $794 across 2 shipments (7.9% of this supplier's total exports)
• M/S. NIKHIL PHARMA P — $789 across 2 shipments (7.9% of this supplier's total exports)
• SALAMA PHARMACEUTICA — $750 across 2 shipments (7.5% of this supplier's total exports)
Key Insight: UNITED BIOTECH PRIVATE LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $436, indicating a broad distribution network with many smaller, regular orders.
6ASPIRA BIOHEALTH LLP
ASPIRA BIOHEALTH LLP is the fifth-largest Topotecan exporter from India, with a market share of 0.3% and a total export value of $9.9K across 5 shipments. Their average shipment value of $2.0K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
ASPIRA BIOHEALTH LLP serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO — $9.9K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: ASPIRA BIOHEALTH LLP operates with high shipment frequency (5 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Topotecan Flows
Once Topotecan leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and VENUS REMEDIES LIMITED, it travels to 5 destination markets with a combined import value of $3.8M. Poland absorbs the largest share at 29.8% ($1.1M), followed by Netherlands (15.7%) and United States (14.9%).
In Poland — the top destination — named importers include ACCORD HEALTHCARE POLSKA SP. Z O.O., ACCORD HEALTHCARE POLSKA SP. Z.O.O., ACCORD HEALTHCARE POLSKA SP. Z O.O. In Netherlands, key buyers are ALLOGA FRANCE, BROCACEF NL : HUB, BROCACEF NL:EU HUB.
This geographic spread reflects Topotecan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Topotecan Go? Top Importing Countries & Their Buyers
Trade flow of Topotecan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Poland
Poland ranks as the first-largest destination for Topotecan imports from India, with a total trade value of $1.1M across 50 shipments — representing a 29.8% share of all Topotecan exports. The average shipment value of $22.4K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Topotecan importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z O.O. is the largest buyer, accounting for 52.7% ($589.6K) of this market's total imports.
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $589.6K (52.7% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. — $236.9K (21.2% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP. Z O.O — $52.5K (4.7% of Poland's total)
Key Insight: Poland's per-shipment average of $22.4K (232% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Topotecan imports from India.
2Netherlands
Netherlands ranks as the second-largest destination for Topotecan imports from India, with a total trade value of $589.3K across 51 shipments — representing a 15.7% share of all Topotecan exports. The average shipment value of $11.6K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Topotecan importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 37.5% ($220.8K) of this market's total imports.
• ALLOGA FRANCE — $220.8K (37.5% of Netherlands's total)
• BROCACEF NL : HUB — $112.4K (19.1% of Netherlands's total)
• BROCACEF NL:EU HUB — $70.0K (11.9% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $11.6K (72% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Topotecan imports from India.
3United States
United States ranks as the third-largest destination for Topotecan imports from India, with a total trade value of $559.7K across 18 shipments — representing a 14.9% share of all Topotecan exports. The average shipment value of $31.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Topotecan importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 83.1% ($465.3K) of this market's total imports.
• EVERSANA LIFE SCIENCES SERVICES,LLC — $465.3K (83.1% of United States's total)
• EVERSANA LIFE SCIENCES SERVICES LLC — $70.2K (12.5% of United States's total)
Key Insight: United States's per-shipment average of $31.1K (362% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Topotecan imports from India.
4Brazil
Brazil ranks as the fourth-largest destination for Topotecan imports from India, with a total trade value of $515.8K across 6 shipments — representing a 13.7% share of all Topotecan exports. The average shipment value of $86.0K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Topotecan importers in Brazil: ACCORD FARMACUTICA LTDA is the largest buyer, accounting for 49.8% ($257.0K) of this market's total imports.
• ACCORD FARMACUTICA LTDA — $257.0K (49.8% of Brazil's total)
• ACCORD FARMACUTICA LTDA. — $170.1K (33.0% of Brazil's total)
Key Insight: Brazil's per-shipment average of $86.0K (1178% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Topotecan imports from India.
5Morocco
Morocco ranks as the fifth-largest destination for Topotecan imports from India, with a total trade value of $111.1K across 2 shipments — representing a 3.0% share of all Topotecan exports. The average shipment value of $55.5K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Topotecan importers in Morocco: M/S. SUN PHARMACEUTICALS MOROCCO LL is the largest buyer, accounting for 56.2% ($62.4K) of this market's total imports.
• M/S. SUN PHARMACEUTICALS MOROCCO LL — $62.4K (56.2% of Morocco's total)
Key Insight: Morocco's per-shipment average of $55.5K (725% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Morocco is a key market for Topotecan imports from India.
People Also Ask — Topotecan Supplier & Trade Network
Who are the top suppliers of Topotecan from India?+
Which companies buy Topotecan from Indian manufacturers?+
Where does Topotecan exported from India go?+
What is the market share of the top Topotecan supplier from India?+
What is the average shipment value for Topotecan exports from India?+
Is Topotecan manufactured in India and exported globally?+
Which country imports the most Topotecan from India?+
Who are the buyers of Topotecan in Netherlands?+
How concentrated is the Topotecan supplier market in India?+
How do I find verified buyers for Topotecan in specific countries?+
Topotecan Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Topotecan exporter with a 30.8% market share and $1.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 45 suppliers collectively account for 37.9% of all tracked Topotecan exports, with a combined trade value of $3.8M.
- 3Poland is the largest destination market, absorbing 29.8% of India's Topotecan exports ($1.1M). Netherlands (15.7%) and United States (14.9%) follow.
- 4With 558 total shipments averaging $6.7K each, the Topotecan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD FARMACUTICA LTDA., E P H K, VENUS PHARMA GMBH — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 51 countries
Network value: $3.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Topotecan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Topotecan.
- 2.Flow Mapping: 45 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 558 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 51 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
558 Verified Shipments
45 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists